Home » Topics » Regulatory » Patents

Patents
RSS

BASF reports new endothelin antagonists

Jan. 16, 1998

Compounds for cardiovascular diseases described by BMS

Jan. 16, 1998

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Modulators of muscarinic receptors claimed by Lilly for AD, psychosis

Jan. 15, 1998

Phthalazine AMPA receptor antagonists claimed by Schering AG

Jan. 15, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...